Organon & Co. (NYSE:OGN) Q1 2025 Earnings Call Transcript
Operator: Hello, and welcome to the Organon First Quarter 2025 Earnings Call and Webcast.
Organon & Co. (OGN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 846,770 | $12,608,405 | -3% | 0.14% |
| 2. | Levin Easterly Partners John Murphy | 486,623 | $7,245,818 | +23% | 0.6% |
| 3. | Beddow Capital Management Ed Beddow And William Tichy | 487,925 | $7,265 | +13% | 2.72% |
| 4. | Neo Ivy Capital Renee Yao | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.77 | 5,500 | Officer | 62,974 | 2025-05-07 | Filing | |
| $9.21 | 8,045 | Officer | 52,489 | 2025-05-06 | Filing | |
| $8.24 | 3,500 | Officer | 46,669 | 2025-05-06 | Filing | |
| $8.82 | 11,400 | Officer | 144,484 | 2025-05-05 | Filing | |
| $8.81 | 34,000 | Officer, Director | 282,731 | 2025-05-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 31,877,252 | $474,652,287 | 0.01% | |
| 2. | 29,701,733 | $442,258,806 | 0.01% | |
| 3. | 10,715,445 | $159,552,976 | 0.05% | |
| 4. | 4,977,078 | $74,108,691 | 2.6% | |
| 5. | 3,684,607 | $54,863,803 | 0.01% |
News See All
10 Deep Value Stocks to Buy Now
Deep value investing is a more extreme form of value investing, focusing on stocks that are not just undervalued but significantly mispriced relative to their intrinsic worth.
12 Best Low Price Pharma Stocks To Invest In Right Now
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...
10 Cheap Pharmaceutical Stocks to Buy According to Analysts
Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of companies that provide patient care, research and development of new medicines...
Organon & Co. (NYSE:OGN) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Celine and I will be your conference operator today.
12 Best Medical Stocks To Buy Under $20
The medical industry plays a crucial role in ensuring the health and safety of populations.
10 Oversold Healthcare Stocks To Invest In
Investing in healthcare stocks during lean economic times is generally regarded as defensive.
Organon & Co. (NYSE:OGN) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Mandeep and I'll be your operator today. At this time, I'd like to welcome everyone to the Organon Q3 2024 earnings call webcast.
Organon & Co. (NYSE:OGN) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing-by. My name is Mandeep, and I'll be your operator today. At this time, I'd like to welcome everyone to the Organon Q2 2024 Earnings Call and Webcast.
Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript
Organon & Co. misses on earnings expectations. Reported EPS is $0.88 EPS, expectations were $0.97. Organon & Co.
Billionaire Hedge Funds
